Gene · 5362
Papers4,083
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 4,083
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Association of Alcohol Consumption with Glaucoma and Related Traits: Findings from the UK Biobank. | Ophthalmol Glaucoma | 2023 | 36481453 | PubTator, text mining | PubMed |
| Agreement of Diagnostic Classification Between Structural Parameters in Pre-Perimetric and Early Perimetric Glaucoma. | J Glaucoma | 2023 | 36477025 | PubTator, text mining | PubMed |
| Fluorescein CorneoGraphy (FCG): Use of a repurposed fluorescein imaging technique to objectively standardize corneal staining. | Ocul Surf | 2023 | 36464234 | PubTator, text mining | PubMed |
| Nonarteritic Anterior Ischemic Optic Neuropathy: Cystic Change in the Inner Nuclear Layer Caused by Edema and Retrograde Maculopathy. | Ophthalmol Sci | 2023 | 36439696 | PubTator, text mining | PubMed |
| RP2-Associated X-linked Retinopathy: Clinical Findings, Molecular Genetics, and Natural History. | Ophthalmology | 2023 | 36423731 | PubTator, text mining | PubMed |
| The clinical implications and molecular features of intrahepatic cholangiocarcinoma with perineural invasion. | Hepatol Int | 2023 | 36418844 | PubTator, text mining | PubMed |
| Activating transcription factor 4 regulates hypoxia inducible factor 1α in chronic hypoxia in pancreatic cancer cells. | Oncol Rep | 2023 | 36416348 | PubTator, text mining | PubMed |
| Hyperreflective Foci in Age-Related Macular Degeneration are Associated with Disease Severity and Functional Impairment. | Ophthalmol Retina | 2023 | 36403926 | PubTator, text mining | PubMed |
| The miR-124-AMPAR pathway connects polygenic risks with behavioral changes shared between schizophrenia and bipolar disorder. | Neuron | 2023 | 36379214 | PubTator, text mining | PubMed |
| BEST1 novel mutation causes Bestrophinopathies in six families with distinct phenotypic diversity. | Mol Genet Genomic Med | 2023 | 36378562 | PubTator, text mining | PubMed |
| Ocular survival after intra-arterial chemotherapy for retinoblastoma improves with accrual of experience and programmatic evolution. | Pediatr Blood Cancer | 2023 | 36349521 | PubTator, text mining | PubMed |
| Investigating Determinants and Evaluating Deep Learning Training Approaches for Visual Acuity in Foveal Hypoplasia. | Ophthalmol Sci | 2023 | 36339947 | PubTator, text mining | PubMed |
| In silico investigation of the therapeutic and prophylactic potential of medicinal substances bearing guanidine moieties against COVID-19. | Chem Zvesti | 2023 | 36312321 | PubTator, text mining | PubMed |
| Multimodal Raman spectroscopy and optical coherence tomography for biomedical analysis. | J Biophotonics | 2023 | 36308009 | PubTator, text mining | PubMed |
| 3D-Bioprinted Phantom with Human Skin Phototypes for Biomedical Optics. | Adv Mater | 2023 | 36305604 | PubTator, text mining | PubMed |
Longitudinal analysis of aqueous humour cytokine expression and OCT-based imaging biomarkers in retinal vein occlusions treated with anti-vascular endothelial growth factor therapy in the IMAGINE study. | Eye (Lond) | 2023 | 36220884 | PubTator, text mining | PubMed |
| Prevalence and risk factors for age-related macular degeneration in a population-based cohort study of older adults in Northern Ireland using multimodal imaging: NICOLA Study. | Br J Ophthalmol | 2023 | 36216411 | PubTator, text mining | PubMed |
| Oct biomarkers of treatment-naive diabetic macular edema in patients with non-proliferative and proliferative diabetic retinopathy. | Eur J Ophthalmol | 2023 | 36131383 | PubTator, text mining | PubMed |
| [Paracentral scotomas associated with COVID-19 infection]. | Ophthalmologie | 2023 | 36085528 | PubTator, text mining | PubMed |
| Comparison of 10-2 and 24-2 Perimetry to Diagnose Glaucoma Using OCT as an Independent Reference Standard. | Ophthalmol Glaucoma | 2023 | 36084839 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5362/papers?page=36